This website uses cookies to improve your experience. Learn more about cookies and how to manage them.

Society news


BJCP article: Colour-graded pictogram label to reduce medicine-related traffic crashes found ineffective

22 Aug 2016

A new study questions the effectiveness of using pictogram message on the labels of anxiety and sleep medications that interfere with driving – an approach this is currently implemented across France. The British Journal of Clinical Pharmacology study found that the risk of being responsible for a crash associated with these medicines did not decrease long-term after the pictogram was introduced.

Recognising top institutions for British Pharmacological Society membership

03 Aug 2016

The Society is a global community at the heart of pharmacology, with over 3,500 members from over 60 countries. Our members are the heart of our Society and ensure that we can continue to lead the way in research and application of pharmacology. Recently, the Society's Membership Committee has been looking at the top institutions for British Pharmacological Society members, and we are keen to share them more widely: King’s College London University College London University...

BJCP article: New lipid-lowering drugs help patients reduce LDL cholesterol

02 Aug 2016

A recent analysis in the British Journal of Clinical Pharmacology indicates that adding new therapies called anti-PCSK9 antibodies to other lipid-lowering treatments can help patients lower their LDL cholesterol levels.

BJP article: Antioxidant therapies may help in the fight against neurodegenerative diseases

02 Aug 2016

A new review in the British Journal of Pharmacology examines the potential of antioxidant approaches for the treatment of neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and multiple sclerosis.

PR&P article: Many physicians still prescribe controversial drug combination

02 Aug 2016

Safety concerns of the concomitant use of clopidogrel with the proton pump inhibitors (PPIs) omeprazole or esomeprazole were published in May 2009 and February 2010 by European regulatory agencies. Findings in study in Pharmacology Research & Perspectives indicate that advice from regulatory authorities were followed, but only reluctantly and not fully, probably partly because of scientific doubt about the interaction.

BJP article: A sage discovery: Plant-derived compounds have potent anti-inflammatory effects

29 Jul 2016

New research reveals that two specific plant-derived compounds may be effective for fighting inflammation and pain. The findings are published in the British Journal of Pharmacology.

Prescribing Safety Assessment guide published for new doctors

22 Jul 2016

From 2016 all new doctors will be required to take the Prescribing Safety Assessment before their first year of practice after graduating (Foundation Year 1) – as announced by the UK’s Foundation Programme Office (UKFPO) on behalf of the Health Departments of England, Wales, Northern Ireland and Scotland.

BJCP article: Many elderly people are receiving and using prescription medications inappropriately

18 Jul 2016

A new study from Belgium indicates that the majority of community-dwelling elderly adults are taking prescription medications inappropriately. The study, which is published in the British Journal of Clinical Pharmacology, also found a link between underuse—not taking essential medications—and an increased risk of dying or needing to be hospitalized.

BJCP article: Risk of low blood sugar differs among similar diabetes drugs

18 Jul 2016

A new systematic review, published in the British Journal of Clinical Pharmacology, of randomized clinical trials lasting 12 to 52 weeks found that when added to metformin, gliclazide confers the lowest risk of hypoglycemia compared with glipizide, glimepiride, and glibenclamide.

BJP article: Beware of antioxidants, warns scientific review

18 Jul 2016

The lay press and thousands of nutritional products warn of oxygen radicals or oxidative stress and suggest taking so-called antioxidants to prevent or cure disease. Professor Pietro Ghezzi at the Brighton and Sussex Medical School and Professor Harald Schmidt at the University of Maastricht have analyzed the evidence behind this. The result is a clear warning: do not take these supplements unless a clear deficiency is diagnosed by a healthcare professional.

New Competency Framework for all Prescribers

14 Jul 2016

A new, updated and restructured Competency Framework for all Prescribers (LINK) has been published today (14 July) by the Royal Pharmaceutical Society (RPS) after collaboration with the British Pharmacological Society, all the prescribing professions and patients.